PL399993A1 - Preparation of the immunosensor and its use to detect influenza virus - Google Patents

Preparation of the immunosensor and its use to detect influenza virus

Info

Publication number
PL399993A1
PL399993A1 PL399993A PL39999312A PL399993A1 PL 399993 A1 PL399993 A1 PL 399993A1 PL 399993 A PL399993 A PL 399993A PL 39999312 A PL39999312 A PL 39999312A PL 399993 A1 PL399993 A1 PL 399993A1
Authority
PL
Poland
Prior art keywords
solution
rinsed
electrodes
immunosensor
influenza virus
Prior art date
Application number
PL399993A
Other languages
Polish (pl)
Other versions
PL223208B1 (en
Inventor
Dawid Nidzworski
Jerzy Radecki
Hanna Radecka
Urszula Jarocka
Bogusław Szewczyk
Original Assignee
Uniwersytet Gdanski
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Gdanski filed Critical Uniwersytet Gdanski
Priority to PL399993A priority Critical patent/PL223208B1/en
Priority to PCT/PL2013/000092 priority patent/WO2014014371A1/en
Publication of PL399993A1 publication Critical patent/PL399993A1/en
Publication of PL223208B1 publication Critical patent/PL223208B1/en

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • G01N33/54373Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08RNA viruses
    • G01N2333/11Orthomyxoviridae, e.g. influenza virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Przedmiotem wynalazku jest sposób przygotowania immunoczujnika do wykrywania wirusa grypy, gdzie czyste złote elektrody płucze się etanolem i umieszcza się w 10 mM etanolowym roztworze 1,6-heksanoditiolu (HDT) na 20 h w temperaturze pokojowej. Następnie elektrody płucze się kolejno etanolem i wodą dejonizowaną oraz odwraca się dołem do góry i nakrapla 10 µl roztworu złota koloidalnego (GCP) na 18 h w +4°C, w kolejnym etapie elektrody płucze się 0.1 M buforem PBS (145 mM NaCl, 2.7 mM KCl, 8.4 mM NaH2PO4, 1.6 mM Na2HPO4) i nakrapla się 10 µl roztworu przeciwciał anty-M o stężeniu 28 µg/ml w 0.1 M buforze PBS na 20 h w +4°C. W ostatnim etapie na powierzchnie elektrod nakrapla się 10 µl roztworu 0.5% (w/v) BSA w 0.1 M PBS na 2 h w +4°C, tak przygotowane elektrody płucze się buforem PBS i przechowuje w temperaturze +4°C do momentu użycia (nie dłużej niż jeden dzień). Ponadto ujawniono zastosowanie immunoczujnika do wykrywania w roztworze białka M oraz wirusa grypy.The subject of the invention is a method for preparing an immunosensor for detecting influenza virus, where clean gold electrodes are rinsed with ethanol and placed in a 10 mM ethanol solution of 1,6-hexanedithiol (HDT) for 20 h at room temperature. Then, the electrodes are rinsed successively with ethanol and deionized water, turned upside down and 10 µl of colloidal gold solution (GCP) is dropped for 18 h at +4°C. In the next step, the electrodes are rinsed with 0.1 M PBS buffer (145 mM NaCl, 2.7 mM KCl, 8.4 mM NaH2PO4, 1.6 mM Na2HPO4) and 10 µl of anti-M antibody solution with a concentration of 28 µg/ml in 0.1 M PBS buffer is added dropwise for 20 h at +4°C. In the last stage, 10 µl of a solution of 0.5% (w/v) BSA in 0.1 M PBS is dropped onto the electrode surfaces for 2 h at +4°C, the electrodes prepared in this way are rinsed with PBS buffer and stored at +4°C until use ( no longer than one day). Furthermore, the use of an immunosensor for detecting M protein and influenza virus in a solution is disclosed.

PL399993A 2012-07-16 2012-07-16 Method for preparing immuno-sensor and its use for the detection of influenza virus PL223208B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
PL399993A PL223208B1 (en) 2012-07-16 2012-07-16 Method for preparing immuno-sensor and its use for the detection of influenza virus
PCT/PL2013/000092 WO2014014371A1 (en) 2012-07-16 2013-07-15 A method of fabrication of an immunosensor and its use for detection of influenza virus

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL399993A PL223208B1 (en) 2012-07-16 2012-07-16 Method for preparing immuno-sensor and its use for the detection of influenza virus

Publications (2)

Publication Number Publication Date
PL399993A1 true PL399993A1 (en) 2014-01-20
PL223208B1 PL223208B1 (en) 2016-10-31

Family

ID=49034154

Family Applications (1)

Application Number Title Priority Date Filing Date
PL399993A PL223208B1 (en) 2012-07-16 2012-07-16 Method for preparing immuno-sensor and its use for the detection of influenza virus

Country Status (2)

Country Link
PL (1) PL223208B1 (en)
WO (1) WO2014014371A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3356823B1 (en) 2015-09-28 2020-04-22 Sensdx Sp. z o.o. A modified bdd substrate and its use as an impedance sensor for detection of biological molecules and a system and method for monitoring pathogens
CN106093139A (en) * 2016-06-29 2016-11-09 中国科学院长春应用化学研究所 A kind of detection method of concentration of methanol solution
CN108663472B (en) * 2018-04-20 2020-06-19 国药集团德众(佛山)药业有限公司 Identification method of rhododendron anthopogonoides essential oil
PL431069A1 (en) * 2019-09-09 2021-03-22 Sensdx Spółka Akcyjna Influenza virus detection kit containing a buffer, a linker and an amino acid sequence and detection method
CN114935648A (en) * 2022-04-19 2022-08-23 谱瑞前海(深圳)智能科技有限公司 Method for generating electric signal from epidemic virus immunodetection result

Also Published As

Publication number Publication date
WO2014014371A1 (en) 2014-01-23
PL223208B1 (en) 2016-10-31

Similar Documents

Publication Publication Date Title
PL399993A1 (en) Preparation of the immunosensor and its use to detect influenza virus
CL2020002012A1 (en) Human anti-rankl antibody formulations and methods of using them. (divisional request 201903032)
CY1123450T1 (en) IL-15/IL-15RA BASED CONJUGATE PURIFICATION METHOD
CY1120414T1 (en) ANTIBODIES CONNECTED TO NO40 AND THEIR USES
BR112013003361A2 (en) antibody, polynucleotide and polypeptide isolated, composition, vector, host cell, method of producing an antibody, antibody conjugate, pharmaceutical formulation, use of the antibody, methods of treating, inducing and diagnosing disease in an individual
AR095432A1 (en) PROTEINS OF UNION TO ANTIGEN
BR112015022210A8 (en) antibody formulations
MX2014005108A (en) POLYPEPTIDE CONSTRUCTS AND THEIR USES.
EA202092884A1 (en) COMPOSITIONS WITH HIGH ANTIBODY CONCENTRATION
NZ719036A (en) Anti-pdl1 antibody formulations
BR112019008702A2 (en) polypeptide, method of decreasing a polypeptide effector function, composition, method of treatment, kit of parts, and use of a polypeptide or composition.
EA201690333A1 (en) Modulokins based on the domain SUSHI IL-15 and IL-15Rα
CY1118200T1 (en) Polypeptides, polynucleotides and compositions for use in the treatment of latent tuberculosis
JP2017515909A5 (en)
DK2709663T3 (en) Use of anti-CGRP antibodies and antibody fragments to prevent or inhibit photophobia or aversion to light in individuals in need thereof, especially migraineurs
EA201000424A1 (en) ANTIBODIES TO IL-23
DK201300193U1 (en) Aluminum compounds for use in therapeutic products and vaccines.
CY1112162T1 (en) Anti-AB antibody
TR201809571T4 (en) IL-22 polypeptides and IL-22 fc fusion proteins and methods of use.
AR076748A1 (en) STABLE FORMULATIONS OF HUMAN ANTI-TNF-ALFA ANTIBODIES WITH LARGE PROTEIN CONCENTRATIONS. TREATMENT METHOD
EA201171494A1 (en) MIMETIC PROTEINS SMAC
BR112015022978A2 (en) bispecific binding agent, its method of production pharmaceutical composition, fusion protein, use, nucleic acid sequence, vector, host cell, method of killing tumor cells and inhibiting tumor growth
PE20120170A1 (en) IMPROVED ANTI-ALBUMIN BINDING VARIANTS
EP4296673A3 (en) Peptides and methods for the detection of lyme disease antibodies
TR201905101T4 (en) Monoclonal antibodies against tissue factor pathway inhibitor (TFPI).